Allergan Plc (AGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2002 | 06-2002 | 03-2002 | 12-2001 | 09-2001 | |
| Sales | 307,860 | 300,074 | 285,690 | 293,910 | 270,942 |
| Cost of Goods | 143,925 | 138,085 | 135,687 | 129,073 | 140,398 |
| Gross Profit | 163,935 | 161,989 | 150,003 | 164,837 | 130,544 |
| Operating Expenses | 95,637 | 94,031 | 94,763 | 95,126 | 279,017 |
| Operating Income | 69,223 | 68,043 | 55,927 | 69,784 | -148,075 |
| Interest Expense | 5,747 | 5,783 | 5,160 | 5,931 | 7,203 |
| Other Income | 700 | 32,909 | 569 | 13,269 | 64,680 |
| Pre-tax Income | 64,176 | 95,169 | 51,336 | 77,122 | -90,598 |
| Income Tax | 23,519 | 35,213 | 19,251 | 30,829 | -31,965 |
| Net Income Continuous | 40,657 | 59,956 | 32,085 | 46,293 | -58,633 |
| Net Income | $40,657 | $59,956 | $32,085 | $46,293 | $-58,633 |
| EPS Basic Total Ops | 0.38 | 0.56 | 0.30 | 0.43 | -0.55 |
| EPS Basic Continuous Ops | 0.38 | 0.56 | 0.30 | 0.43 | -0.55 |
| EPS Diluted Total Ops | 0.38 | 0.56 | 0.30 | 0.43 | -0.55 |
| EPS Diluted Continuous Ops | 0.38 | 0.56 | 0.30 | 0.44 | -0.55 |
| EBITDA(a) | $91,900 | $88,958 | $75,247 | $95,423 | $-125,496 |